Guggenheim raises Oruka Therapeutics stock price target to $200 on trial data
Astrana Health Inc stock hits 52-week high at 34.81 USD
Iran offers to reopen Strait of Hormuz, but Trump seems unlikely to accept
Paramount seeks FCC approval for foreign investors helping fund Warner Bros acquisition
Shell reverses course in Canada and buys ARC Resources for $14 billion, doubling down on oil and gas
Newsletter
Subscribe to get the latest news, offers and special announcements.


